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ABSTRACT
Background and Purpose: Multiple sclerosis (MS) is a disease determined by the interaction 
of genetic and environmental factors. Metals are suspected of being involved in MS. There is 
not any epidemiologic study about mines and MS. The purpose of this study was to determine 
MS prevalence according to mines in Kerman province.
Methods: This cross-sectional study was conducted on 932 patients in Kerman province in 
2012. The details of the patients including age, sex, age at the onset of disorder and disease 
duration were collected from documents of MS centres of Kerman and Rafsanjan Universities 
of Medical Science. Diagnosis was confirmed according to the revised Mc-Donald criteria. To 
analyze the data, SPSS-17 software and descriptive statistics and t-test were used
Results: The male/ female ratio was 1:3. The prevalence of MS in Kerman province was 
31.7 per 100000. Kerman, Sirjan, Zarand and Rafsanjan had the highest prevalence of MS, 
respectively. The mean prevalence of MS in mineral areas in Kerman province (Kahnoj, Sirjan, 
Zarand, Rafsanjan, Baft, Shahrbabak) was 23.01±10.78 and in non-mineral areas (Kerman, 
Bam, Jiroft) was 39.56±20.34 that show the higher prevalence of MS in non-mineral areas of 
Kerman province.
Conclusion: Our findings showed that prevalence of MS is lower in mineral areas and probably, 
living in these areas isn’t a predisposing factor for MS.
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INTRODUCTION
Multiple sclerosis (MS) is the most common 
inflammatory-demyelinating disease of the central 
nervous system and also, the most frequent cause of 
non-traumatic neurologic disability in young and middle-
age adults 1. Our knowledge about its pathogenesis 
is still incomplete and etiology remains unknown, 
but according to current data the disease develops in 
genetically susceptible individuals and may require 
additional environmental triggers 2. Probably, the immune 
process is a consequence of the connections between 
environment and susceptibility genes 3. Infective disease, 
dietary, habits (such as smoking), industrial exposure, 
and living in ecological hazard areas could be considered 
environmental factors 4,5. Early observations showed that 
the prevalence of MS is variable among geographic areas 
but we still don’t have any confirmed data about the 
nature of these pathologic factors in ecological hazard 
areas 6. One of the most geographic differences among 
areas of the world is mines existence. Also, available 
articles provide evidences of the effect of metals in 
MS pathogenesis 7-9. For example, iron 10, selenium 11, 
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copper 12, calcium 13, lead 3, aluminium 14 are only a 
small part of a big list of metals that have introduced 
in MS pathogenesis. Not only researches in the other 
countries but also some studies in Iran have confirmed 
an imbalance in serum and CSF level of trace elements 
in MS patients 12,15-17. According to our review in many 
medical resources including Pubmed, there isn’t any 
published epidemiologic study about prevalence of MS 
related to mines. Because Kerman province is a vest state 
with several important and different mines, we decided 
to do this research in this area. Our project is the first 
pilot study in this field and helps to identify the effect 
of environmental factors on MS pathogenesis.
PATIENTS AND METHODS
Our study was conducted in Kerman province. It covers 
an area of 181,714 km2 and includes 11% of the total area 
of the country. It is located in the south-eastern part of 
the country bounded by the provinces of Hormozgan in 
the south, Yazd and South Khorasan in the north, Fars 
in the west and the provinces of Sistan and Balochestan 
in the east. The main townships of Kerman province are; 
Baft, Bam, Jiroft, Rafsanjan, Zarand, Sirjan, Shahrbabak, 
Kahnoj and Kerman. The main mines in province of 
Kerman are iron, cooper, chrome and titanium. The 
province has a population of approximately 3 millions 
according to the national census in 2011 18.
Data collection
This cross-sectional study was conducted on 932 
patients in 2012. All of them were known cases of MS 
and resident in Kerman province. The disease data were 
collected from documents of MS centres of Kerman 
and Rafsanjan Universities of Medical Science 19. They 
were all diagnosed with MS by a neurologist and the 
MS committees (including at least 3 neurologists) in 
Kerman and Rafsanjan Universities of Medical Science 
had confirmed the diagnosis according to the revised 
Mc-Donald criteria 2010 20. The details of the patients 
including age, sex, age at the onset of disorder and disease 
duration were extracted from the records. The study was 
approved by the Neurology Research Centre of Kerman 
University of Medical Sciences.
Statistical analyses
Prevalence was defined as the total number of patients 
with a diagnosis of MS per 100,000 inhabitants. To analyze 
the data, SPSS-17 software and descriptive statistics (mean, 
frequency percent, and standard deviation) and t-test were 
used and p≤0.05 was considered statistically significant.
RESULTS
In the present study, 932 patients were evaluated. The 
male/female ratio was 1:3. The mean age of male and 
female were 38.1±9.72 and 36.12±9.97, respectively. 
Mean age at the onset of disease was 28.35 years (29±8.73 
for men and 28±8.3 for women) (P<0.05). Also, the mean 
duration of illness was 8.2±1 year (8.4±1.2 for men and 
8.7±0.5 for women) (P=0.30). The prevalence of MS in 
Kerman province was 31.7 per 100000. Kerman, Srjan, 
Zarand and Rafsanjan had the highest prevalence of 
MS respectively (Table 1). The mean prevalence of MS 
in mineral areas in Kerman province (Kahnoj, Sirjan, 
Zarand, Rafsanjan, Baft, Shahrbabak) was 23.01±10.78 
and in non-mineral areas (Kerman, Bam, Jiroft) was 
39.56±20.34 that show the higher prevalence of MS in 
non mineral areas of Kerman province. In addition, the 
highest prevalence of MS was seen in the areas that had 
chrome, iron and cooper mines, respectively (Table 2).
CONCLUSION
Our study evaluated the prevalence of MS according 
to mines in Kerman province. Our findings show that 
the prevalence of MS is higher in non mineral areas in 
comparison mineral areas. In addition, our study showed 
that the prevalence of MS in all kind of mines is lower than 
mean prevalence of MS in non-mineral areas (Table 1,2). 
We have not find any similar articles in literature review to 
compare our results with them It seems that our research 
is the first in this field. According our findings, we think 











Kerman province 31.7 
Table 1. Prevalence of MS in Kerman province and main townships.
Mine Township Prevalence
Iron Sirjan, Zarand 29.6
Cooper Rafsanjan, Shahrbabak 22.5
Chrome Baft 31
Titanium Kahnoj 1.9
Non Kerman, Bam, Jiroft 39.5
Table 2. Prevalence of MS according to mines in townships of 
Kerman province.
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MS genesis and we should search for other environmental 
factors in MS etiology. However, we are confronted with 
the following facts about trace elements. First, available 
literature provides evidences of abnormal level of trace 
elements in clinically definite MS and also clinically 
isolated syndrome 21-24. These studies are done on serum, 
cerebrospinal fluid, urine and hair 7,10,25-27 and including 
metals such as magnesium 28, iron 10, mercury 29, selenium 
11, copper 12,30, calcium 13, zinc, chrome, lead, titanium 
3,30, aluminum and many others 14. Second, in MS animal 
models, some metals (such as copper) have been seen to 
attenuate experimental autoimmune encephalomyelitis, 
this fact would suggest a role of metals in MS initiation 
and progression 31. Third, some studies showed a gradual 
accumulation of some metals (for example iron) in MS 
patients’ brain especially in oligodendrocytes 32,33. Since 
the main role of oligodendrocyte is myelin production 
and the myelin sheath of neurons are damaged in this 
disease, probably an imbalance of metals may lead to 
brain tissue inflammation and eventually to MS disease 
25,28,34. Forth, some metals (such as zinc, and mercury) 
are involved in autoimmunity response such as cytokine 
production, and we know that inflammation is a main 
picture of MS 29,35. Also, trace elements are crucial for 
the development of the nervous system, myelination of 
the nerve fibers, and neuronal excitability. The ability 
of metals to promote neuronal damage and neurological 
dysfunction has been linked to their role in catalyzing 
the formation of superoxide anion (O2.-), singlet oxygen 
(1O2) and hydrogen peroxide H2O2, which, in turn, are 
important mediators of oxidative reactions of biological 
macromolecules involved in neurodegenerative processes 
27-36. According to these facts (that show the effects of 
minerals on MS) and our finding (that show the low 
prevalence of MS in mineral areas) we hypothesize that 
the nature of these metal abnormalities is related to MS 
pathogenesis than environmental effect.
It should be noted that our study was a pilot 
epidemiologic study and the results should be evaluated 
with caution. Still it is unclear metal interactions are a 
primary or secondary factor, or a consequence of the 
neurodegeneration and further studies in this field are 
needed. Lack of evaluation of place of birth and migration 
were our study limitations and should be corrected in 
further studies. In conclusion, our findings showed that 
prevalence of MS is lower in mineral areas and probably, 
living in these areas isn’t a predisposing factor for MS.
ACKNOWLEDGMENTS
We would to appreciate all MS patients. We also 
wish to thank Neurology Research Canter of Kerman 
and Kerman branch of Iranian MS society.
REFERENCES
1. Kruger D. Multiple sclerosis. JAAPA. 2012;25(7):54-5.
2. Scherer C, Dubas F. Multiple sclerosis. Rev Prat. 2009; 
59(5):695-701.
3. Forte G, Visconti A, Santucci S, Ghazaryan A, Figà-
Talamanca L, Cannoni S, et al. Quantification of chemical 
elements in blood of patients affected by multiple sclerosis. 
Ann Ist Super Sanita. 2005;41(2):213-6.
4. Spirin NN, Kachura DA, Ershov MB, Dzhurko IuA, Shitov 
LN. Clinical and epidemiological peculiarities of multiple 
sclerosis in patients with different level of essential and 
toxic chemicals in blood serum. Zh Nevrol Psikhiatr Im S 
S Korsakova.2011;111(2 Pt 2):10-5.
5. Alonso A, Cook SD, Maghzi AH, Divani AA. A case-control 
study of risk factors for multiple sclerosis in Iran. Mult 
Scler.2011;17(5):550-5.
6. Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi 
J, Pakdaman H. Multiple sclerosis in Iran: a demographic 
study of 8,000 patients and changes over time. Eur 
Neurol.2010;64(6):331-6.
7. Melø TM, Larsen C, White LR, Aasly J, Sjøbakk TE, Flaten 
TP, et al. Manganese, copper, and zinc in cerebrospinal fluid 
from patients with multiple sclerosis. Biol Trace Elem Res. 
2003;93(1-3):1-8.
8. Zapadniuk BV. The incidence of multiple sclerosis and the 
content of cobalt, boron, zinc, manganese and molybdenum 
in the arable soils of different climatic zones of Ukraine. 
Lik Sprava. 1992;(1):111-3.
9. Layton W, Sutherland JM. Geochemistry and multiple 
sclerosis: a hypothesis. Med J Aust. 1975; 18;1(3):73-7.
10. Exley C, Mamutse G, Korchazhkina O, Pye E, Strekopytov 
S, Polwart A, et al. Elevated urinary excretion of aluminium 
and iron in multiple sclerosis. Mult Scler. 2006;12(5):533-40.
11. Sanmartin C, Plano D, Font M, Palop JA. Selenium and 
clinical trials: new therapeutic evidence for multiple diseases. 
Curr Med Chem.2011;18(30):4635-50.
12. Ghazavi A, Kianbakht S, Ghasami K, Mosayebi G. High 
copper and low zinc serum levels in Iranian patients with 
multiple sclerosis: a case control study. Clin Lab. 2012;58(1-
2):161-4.
13. Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna 
JP, Lilius EM, Mononen I. A longitudinal study of serum 
25-hydroxyvitamin D and intact parathyroid hormone 
levels indicate the importance of vitamin D and calcium 
homeostasis regulation in multiple sclerosis. J Neurol 
Neurosurg Psychiatry. 2008;79(2):152-7.
14. Komatsu F, Kagawa Y, Kawabata T, Kaneko Y, Kudoh H, 
Purvee B, et al. Influence of essential trace minerals and 
micronutrient insufficiencies on harmful metal overload in 
a Mongolian patient with multiple sclerosis. Curr Aging 
Sci 2012 Jul;5(2):112-25.
Multiple Selerosis and Mines—Iranmanesh et al
136 International Clinical Neuroscience Journal  •  Vol 2, No 4, Autumn 2015
15. Iranmanesh M, Iranmanesh F, Sadeghi H. Serum level of 
iron, zinc and copper in patients with multiple sclerosis. 
JJUMS. 2013; 10 (4) :1-5
16. Nasrabadi, M. Forghani, D. Shahabi, I. Shirini, R. 
Determination of trace elements in blood samples of patients 
affected by multiple sclerosis from Iran by neutron activation 
analysis. Journal of Radioanalytical & Nuclear Chemistry. 
2012; 293 (2) :479.
17. Attar AM, Kharkhaneh A, Etemadifar M, Keyhanian K, 
Davoudi V, Saadatnia M.Serum Mercury Level and Multiple 
Sclerosis. Biological Trace Element Research. 2012; 146(2): 
150-153.
18. Boshrabadi H M, Villano R, Fleming E. Technical efficiency 
and environmental-technological gaps in wheat production 
in Kerman province of Iran. Agricultural Economics.2008; 
38(1) : 67–76.
19. Ebrahimi H A, Sedighi B. Prevalence of multiple sclerosis 
and environmental factors in Kerman province, Iran.
Neurology Asia.2013; 18(4) : 385 – 389.
20. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, 
Filippi M, et al. Diagnostic criteria for multiple sclerosis: 
2010 revisions to the McDonald criteria. Annals of neurology. 
2011; 69 (2): 292–302
21. Ristori G, Brescianini S, Pino A, Visconti A, Vittori D, 
Coarelli G, et al. Serum elements and oxidative status in 
clinically isolated syndromes: imbalance and predictivity. 
Neurology. 2011;76(6):549-55.
22. Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A, et al. 
Iron is a sensitive biomarker for inflammation in multiple 
sclerosis lesions. PLoS One. 2013;8(3):e57573.
23. Irvine DG, Schiefer HB, Hader WJ. Geotoxicology of 
multiple sclerosis: the Henribourg, Saskatchewan, cluster 
focus. II. The soil. Sci Total Environ. 1988;77(2-3):175-88.
24. Alimonti A, Ristori G, Giubilei F, Stazi MA, Pino A, Visconti 
A, et al. Serum chemical elements and oxidative status 
in Alzheimer’s disease, Parkinson disease and multiple 
sclerosis. Neurotoxicology. 2007;28(3):450-6.
25. Iranmanesh F, Bakhsgi H, Akbaripoor A. Serum iron and 
ferritin in patients with multiple sclerosis. Zahedan J Res 
Med Sci. 201 3; 1 5 (4): 39 – 42.
26. Ryan DE, Holzbecher J, Stuart DC. Trace elements in 
scalp-hair of persons with multiple sclerosis and of normal 
individuals. Clin Chem. 1978;24(11):1996-2000.
27. Tamburo E, Varrica D, Dongarrà G, Grimaldi LM. 
Trace elements in scalp hair samples from patients 
with relapsing-remitting multiple sclerosis. PLoS One. 
2015;10(4):e0122142.
28. Johnson S. The possible role of gradual accumulation of 
copper, cadmium, lead and iron and gradual depletion 
of zinc, magnesium, selenium, vitamins B2, B6, D and 
E and essential fatty acids in multiple sclerosis. Med 
Hypotheses.2000;55:239-41.
29. Siblerud RL, Kienholz E. Evidence that mercury from silver 
dental fillings may be an etiological factor in multiple 
sclerosis. Sci Total Environ.1994;141:191-205.
30. Sedighi B, Ebrahimi H A, Haghdoost A, Abotorabi M. 
Comparison of serum levels of copper and zinc among 
multiple sclerosis patients and control group. Iranian Journal 
of Neurology.2013. 12(4):125-128.
31. Offen D, Gilgun-Sherki Y, Barhum Y, Benhar M, Grinberg 
L, et al. A low molecular weight copper chelator crosses the 
blood-brain barrier and attenuates experimental autoimmune 
encephalomyelitis. J Neurochem.2004;89(5):1241-51.
32. Khalil M, Langkammer C, Pichler A, Pinter D, Gattringer 
T, Bachmaier G, et al. Dynamics of brain iron levels in 
multiple sclerosis: A longitudinal 3T MRI study. Neurology. 
2015;84(24):2396-402.
33. Raz E, Branson B, Jensen JH, Bester M, Babb JS, Herbert 
J, et al. Relationship between iron accumulation and white 
matter injury in multiple sclerosis: a case-control study. J 
Neurol. 2015;262(2):402-9.
34. Habib CA, Liu M, Bawany N, Garbern J, Krumbein I, 
Mentzel HJ, et al. Assessing abnormal iron content in the 
deep gray matter of patients with multiple sclerosis versus 
healthy controls. AJNR Am J Neuroradiol. 2012;33(2):252-8.
35. Earl C, Chantry A, Mohammad N, Glynn P. Zinc ions 
stabilise the association of basic protein with brain myelin 
membranes. J Neurochem. 1988;51:718-24.
36. Aspli KT, Flaten TP, Roos PM, Holmøy T, Skogholt JH, 
Aaseth J. Iron and copper in progressive demyelination--
New lessons from Skogholt’s disease. J Trace Elem Med 
Biol. 2015;31:183-7.
